Also written as Miacalcin (injection), nasal spray sold as a generic
Calcitonin-salmon is a calcitonin receptor agonist. It is filed in this library under bones & muscles, a navigation topic rather than a statement of where it acts. As a regulatory matter it has at least one product approved by the FDA. It is also written as Miacalcin (injection), nasal spray sold as a generic.
Regulatory status
Calcitonin-salmon has an FDA-approved product on the U.S. market, marketed as Calcitonin Salmon under application ANDA215864.
The current label is held by Zydus Pharmaceuticals USA Inc.
From the FDA label
alcitonin salmon injection, synthetic is a calcitonin, indicated for the following conditions: Treatment of symptomatic Paget's disease of bone when alternative treatments are not suitable Treatment of hypercalcemia Treatment of postmenopausal osteoporosis when alternative treatments are not suitable. Fracture reduction efficacy has not been demonstrated Limitations of Use: Due to the possible association between malignancy and calcitonin salmon use, the need for continued therapy should be re-evaluated on a periodic basis ( 1.4, 5.3 ) 1.1 Treatment of Paget’s Disease of Bone Calcitonin salmon injection is indicated for the treatment of symptomatic Paget's disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphatase and urinary hydroxyproline excretion.Quoted from the FDA-approved prescribing information
The evidence
One source on Calcitonin-salmon, resolved to its journal of record. The title is listed so you can judge the evidence rather than take a summary on trust.
Nearby
Markers on this pathway
Calcitonin-salmon's FDA-approved label indicates it for a bone or parathyroid condition. These are the markers clinicians use when assessing calcium and bone turnover. They are listed here so you can read about them, not as a statement that Calcitonin-salmon changes any of them.
A 60-second questionnaire, reviewed by a U.S.-licensed physician.
Find my protocolEducational reference only. This page explains what has been published about Calcitonin-salmon. It is not medical advice, it is not a diagnosis, and it carries no dosing information of any kind. OPTML does not offer or supply this compound unless a product page on this site says otherwise.
Treatment decisions are made by a licensed physician after an individual evaluation. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
All 150 peptides